Expert believes new technology can help fight cancer
Professor Fatemeh Vafaee of the University of NSW is utilizing artificial intelligence to accelerate drug discovery and improve cancer treatment outcomes. Her lab uses AI to predict synergistic drug combinations, significantly reducing the time and cost associated with traditional pharmaceutical research.
Why it matters
AI-driven drug development has the potential to revolutionize medicine by making complex treatments for rare diseases more accessible and efficient.
Save You have reached your maximum number of saved items.
Remove items from your saved list to add more.
Gift Gift icon 0 / 3 No gift articles left
You've used all of your gift articles. 3 more will become available on the 1st of every month.
Share A A A Personalised medication, drugs to combat the rarest of cancers, knowledge of our individual cell interactions and even pre-empting disease in the body – one Sydney lab is working on all of these possibilities and more, thanks to the advent of artificial intelligence.
“I’ve become very interested in how we can leverage AI to save lives and improve the patient outcomes,” said Professor Fatemeh Vafaee, deputy director of the University of NSW’s AI institute and a professor in the school of biotechnology and biomolecular sciences.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in